FASEB publications explore regenerative medicine and 3D bioprinting

By | November 3, 2016

The Federation of American Societies for Experimental Biology (FASEB) is pleased to announce the release of two new publications highlighting regenerative medicine and three-dimensional (3D) bioprinting. The articles are part of FASEB’s Breakthroughs in Bioscience and Horizons in Bioscience series, respectively.

Regenerative Medicine: Advances from the Convergence of Biology & Engineering, Breakthroughs in Bioscience

Throughout history, medical experts have dreamed of repairing wounds that won’t heal, replacing a disfiguring scar with healthy skin, growing replacement lungs in the laboratory, and replacing a leg lost to injury or disease. In the past 20 years, rapid advances in medicine and surgery, developmental and stem cell biology, biochemistry and bioengineering, and the material and physical sciences have resulted in technology and products that improve human health. “Regenerative Medicine: Advances from the Convergence of Biology & Engineering” explores the fields of developmental biology and tissue engineering and how they come together to propel the field of regenerative medicine.

3D Bioprinting: A New Dimension in Tissue Engineering, Horizons in Bioscience

In 1984, Charles Hull patented a process he called “stereolithography,” which is now called 3D printing. The technology has since been used to manufacture rocket engines, custom-fit athletic shoes, and other 3D printers. Important possibilities using 3D printing are also emerging in the medical field. “3D Bioprinting: A New Dimension in Tissue Engineering” examines how researchers are adapting this exciting technology to replace human tissue and organs that have been damaged by trauma or disease.

Breakthroughs in Bioscience is a collection of illustrated articles that highlight recent developments in basic biomedical research and explain how they impact medicine and human health. Horizons in Bioscience are short, illustrated articles describing scientific discoveries on the brink of clinical application. Print and audio versions of both articles are available online at no cost.